Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500097877Phase 4Not yet recruiting
Phase 4 trial of esketamine and propofol in arrhythmogenic cardiomyopathy (ACM) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Mechanical ventilation time. Planned start Feb 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500097877.